Evidence map›Paper›PMID 32508976›Full record

ArticleComputational and mathematical methods in medicine2020

Auxiliary Medical Decision System for Prostate Cancer Based on Ensemble Method.

Jia Wu, Qinghe Zhuang, Yanlin Tan

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jia WuSchool of Computer Science and Engineering, Central South University, Changsha 410083, China.ORCID https://orcid.org/0000-0001-9013-0818
Qinghe ZhuangSchool of Computer Science and Engineering, Central South University, Changsha 410083, China.
Yanlin Tan"Mobile Health" Ministry of Education-China Mobile Joint Laboratory, Changsha 410083, China.ORCID https://orcid.org/0000-0002-5792-2271

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the main diseases that endanger men's health worldwide. In developing countries, due to the large number of patients and the lack of medical resources, there is a big conflict between doctors and patients. To solve this problem, an auxiliary medical decision system for prostate cancer was constructed. The system used six relevant tumor markers as the input features and employed classical machine learning models (support vector machine and artificial neural network). Stacking method aimed at different ensemble models together was used for the reduction of overfitting. 1,933,535 patient information items had been collected from three first-class hospitals in the past five years to train the model. The result showed that the auxiliary medical system could make use of massive data. Its performance is continuously improved as the amount of data increases. Based on the system and collected data, statistics on the incidence of prostate cancer in the past five years were carried out. In the end, influence of diet habit and genetic inheritance for prostate cancer was analyzed. Results revealed the increasing prevalence of PCa and great negative impact caused by high-fat diet and genetic inheritance.

Indexed as

Clinical Decision-MakingDiagnosis, Computer-AssistedBiomarkers, TumorChinaComputational BiologyDecision TreesDiet, High-FatGenetic Predisposition to DiseaseHumansIncidenceMaleNeural Networks, ComputerPrevalenceProstatic NeoplasmsSupport Vector MachineBiomarkers, Tumor

Identifiers

PMID32508976
PMCPMC7251439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.